Sun Life is a high-quality, globally diversified insurer with powerful Asian growth and strong ROE, but MFS outflows, capital strain from alternatives acquisitions and a premium valuation keep the risk-reward balanced.
Overview
Sun Life remains a financially sound, well-managed insurer with strong underlying profitability despite weak reported earnings. Q1 2026 underlying net income was stable at **C$1.05B**, while reported net income fell 50% due to transaction costs, legal provisions and interest-rate adjustments. Underlying ROE stayed strong at **18.6%**, AUM reached **C$1.58T**, and the dividend was raised. Growth in Asia and resilient North American health/wealth businesses offset ongoing MFS active equity outflows and reduced capital flexibility after major SLC acquisitions.